Skip to main content
Clinical Trials/CTRI/2025/10/095520
CTRI/2025/10/095520Not yet recruitingPhase 3

Respiratory muscle training as an adjunct to conventional rehabilitation: a pilot study on enhancing endurance and performance in injured athletes

Akshaya Momula1 site in 1 country12 target enrollmentStarted: October 12, 2025Last updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
12
Locations
1
Primary Endpoint
Pulmonary function test -FEV1, FVC, FEV/FVC [ Forced expiratory volume in first second , forced vital capacity, FEV/FVC-ratio]

Study Overview

Brief Summary

Athletic events results in sports injuries that have the effect of interfering with respiratory efficiency and endurance; thus resulting in longer healing and poorer athletic performance. Traditional treatment methods target the injured location mostly disregarding the respiratory system in recovery of the functional capacity. Respiratory Muscle Training (RMT), notably the Inspiratory Muscle Training (IMT) has proven to build breathing muscles, increasing oxygen uptake, and minimizing fatigue, which leads to faster and more efficient recovery. This pilot randomized control trial proposes to answer the question concerning the effect of RMT as an adjunct to conventional rehabilitation to lower limb-injured athletes aged between 18 and 25 years. Twelve participants will also be placed into an intervention and a control group and perform RMT and standard rehabilitation respectively within a course of four weeks. Pre and post-interventional measures will comprise Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), Maximal Inspiratory Pressure (MIP) and Maximal Expiratory Pressure (MEP). This study will obtain preliminary evidence regarding whether RMT improved respiratory function, endurance, and performance outcomes and, thus, may be a cost-effective, non-invasive way to optimize rehabilitation and possibly an expedited return to sport.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Participant Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 25.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.Athletes with lower limb injuries 2.Both genders 3.Endurance and breathing loss 4.Sports participation with in 6months required 5.Willing to participate.

Exclusion Criteria

  • 1.Any lung diseases 2.Any Cardiovascular conditions 3.Recent abdominal surgeries 4.Smoker 5.Recent respiratory infections.

Outcomes

Primary Outcomes

Pulmonary function test -FEV1, FVC, FEV/FVC [ Forced expiratory volume in first second , forced vital capacity, FEV/FVC-ratio]

Time Frame: It will assessed pre-intervention and post-intervention(0 week-4th week)

Maximal expiratory pressure[MEP]

Time Frame: It will assessed pre-intervention and post-intervention(0 week-4th week)

Maximal inspiratory pressure[ MIP]

Time Frame: It will assessed pre-intervention and post-intervention(0 week-4th week)

Secondary Outcomes

  • Improvement in endurance and performance capacity of athletes (post-rehabilitation).

Investigators

Sponsor
Akshaya Momula
Sponsor Class
Other [Self funded]
Responsible Party
Principal Investigator
Principal Investigator

Dr Thiagarajan Subramanian

Lovely professional university

Study Sites (1)

Loading locations...

Similar Trials